Agios Pharmaceuticals, Inc.
Clinical trials sponsored by Agios Pharmaceuticals, Inc., explained in plain language.
-
New drug trial aims to boost blood health in sickle cell patients
Disease control Recruiting nowThis study is testing a new drug called tebapivat to see if it can improve anemia in people with sickle cell disease. Researchers will compare the drug to a placebo in 56 participants to find the best dose and check its safety. The main goal is to see if the drug increases hemogl…
Phase: PHASE2 • Sponsor: Agios Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
First human test for new drug begins
Knowledge-focused Recruiting nowThis is the first study in people for a new drug called AG-236. Its main goal is to check if a single injection is safe and well-tolerated in healthy volunteers. Researchers will also measure how the drug moves through and leaves the body. The results will help decide if AG-236 c…
Phase: PHASE1 • Sponsor: Agios Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC